Cary Street Partners Investment Advisory’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-161
Closed -$19.2K 1173
2023
Q3
$19.2K Buy
161
+146
+973% +$21.8K ﹤0.01% 1140
2023
Q2
$2.67K Hold
15
﹤0.01% 1545
2023
Q1
$2.47K Sell
15
-22
-59% -$3.79K ﹤0.01% 1472
2022
Q4
$5.83K Buy
+37
New +$5.63K ﹤0.01% 1296

Other funds holding ICUI

Cary Street Partners Investment Advisory's ICUI Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of ICU Medical (ICUI) in Q4 2023, closing a stake of 161 shares — an estimated $19.2K sold.

Cary Street Partners Investment Advisory first reported a position in ICUI in Q4 2022 and held it in 4 quarters. The position peaked at $19.2K in Q3 2023. 241 funds tracked by Wall St. Rank hold ICUI as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining ICU Medical position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 161 ICU Medical shares in Q4 2023, an estimated $19.2K.
  • Cary Street Partners Investment Advisory first reported a position in ICU Medical in Q4 2022 and held it in 4 quarters.
  • Cary Street Partners Investment Advisory's ICU Medical position peaked at $19.2K in Q3 2023.
  • 241 funds tracked by Wall St. Rank held ICU Medical as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.